Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 6, 2005, Pages 3230-3235

  Blum, Claudine A ^a   Müller, Beat ^a   Huber, Peter ^a   Kraenzlin, Marius ^a   Schindler, Christian ^b   De Geyter, Christian ^a   Keller, Ulrich ^a   Puder, Jardena J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ESTRADIOL; INSULIN; MARKER; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLICULAR PHASE; HEMOCONCENTRATION; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LEAN BODY WEIGHT; LUTEAL PHASE; MEASUREMENT; MENSTRUAL CYCLE; MODEL; OBESITY; OVARY FUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ADIPOSE TISSUE; BLOOD; BODY WEIGHT; COMPARATIVE STUDY; GLUCOSE BLOOD LEVEL; HISTOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIODENSITOMETRY; REFERENCE VALUE; REGRESSION ANALYSIS;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DENSITOMETRY, X-RAY; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LUTEINIZING HORMONE; MENSTRUAL CYCLE; OBESITY; REFERENCE VALUES; REGRESSION ANALYSIS; SEX HORMONE-BINDING GLOBULIN;

EID: 21244469503     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0231     Document Type: Article

References (37)

1. Forouhi NG, Sattar N, McKeigue PM 2001 Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 25:1327-1331
2. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR 2002 Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557-1565
3. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV 1991 Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134-5138
4. Davison S, Davis SR 2003 New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 88:2470-2478
5. Bismar H, Diel I, Ziegler R, Pfeilschifter J 1995 Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 80:3351-3355
6. Vongpatanasin W, Tuncel M, Wang Z, Arbique D, Mehrad B, Jialal I 2003 Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol 41:1358-1363
7. Silvestri A, Gebara O, Vitale C, Wajngarten M, Leonardo F, Ramires JA, Fini M, Mercuro G, Rosano GM 2003 Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation 107:3165-3169
8. Sattar N, Forouhi NG, Wild RA 2000 C-reactive protein and hormone replacement therapy. Circulation 102:E96-E97
9. Puder JJ, Freda PU, Goland RS, Wardlaw SL 2001 Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. J Clin Endocrinol Metab 86:2403-2408
10. Rogers A, Eastell R 2001 The effect of 17β-estradiol on production of cytokines in cultures of peripheral blood. Bone 29:30-34
11. Chiu KM, Arnaud CD, Ju J, Mayes D, Bacchetti P, Weitz S, Keller ET 2000 Correlation of estradiol, parathyroid hormone, interleukin-6, and soluble interleukin-6 receptor during the normal menstrual cycle. Bone 26:79-85
12. Gorai I, Taguchi Y, Chaki O, Kikuchi R, Nakayama M, Yang BC, Yokota S, Minaguchi H 1998 Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle. J Clin Endocrinol Metab 83:326-332
13. Diamond MP, Simonson DC, DeFronzo RA 1989 Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril 52:204-208
14. Valdes CT, Elkind-Hirsch KE 1991 Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocrinol Metab 72:642-646
15. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT 2004 Testosterone and sex hormonebinding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27:1036-1041
16. Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA, Atkin SL 2003 The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. J Clin Endocrinol Metab 88:1528-1533
17. Jayagopal V, Kilpatrick ES, Jennings PE, Holding S, Hepburn DA, Atkin SL 2004 The biological variation of sex hormone-binding globulin in type 2 diabetes: implications for sex hormone-binding globulin as a surrogate marker of insulin resistance. Diabetes Care 27:278-280
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
19. Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S 2000 Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use. J Clin Endocrinol Metab 85:35-41
20. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E 2001 Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47:444-450
21. Hamelin BA, Methot J, Arsenault M, Pilote S, Poirier P, Plante S, Bogaty P 2003 Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women. Am J Med 114:599-602
22. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
23. Brooks-Asplund EM, Tupper CE, Daun JM, Kenney WL, Cannon JG 2002 Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women. Cytokine 19:193-200
24. Pacifici R 1996 Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051
25. Fernandez-Real JM, Gutierrez C, Vendrell J, Casamitjana R, Ricart W 2000 Plasma soluble tumor necrosis factor-α receptors circulate in proportion to leptin levels during the menstrual cycle in lean but not in obese women. Eur J Endocrinol 143:235-241
26. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
27. Chiu KM, Ju J, Mayes D, Bacchetti P, Weitz S, Arnaud CD 1999 Changes in bone resorption during the menstrual cycle. J Bone Miner Res 14:609-615
28. Critchley HO, Kelly RW, Brenner RM, Baird DT 2001 The endocrinology of menstruation-a role for the immune system. Clin Endocrinol (Oxf) 55:701-710
29. Yki-Jarvinen H 1984 Insulin sensitivity during the menstrual cycle. J Clin Endocrinol Metab 59:350-353
30. Toth EL, Suthijumroon A, Crockford PM, Ryan EA 1987 Insulin action does not change during the menstrual cycle in normal women. J Clin Endocrinol Metab 64:74-80
31. Abbasi F, Reaven GM 2002 Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 51:235-237
32. Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA, Atkin SL 2002 Biological variation of homeostasis model assessment-derived insulin resistance in type 2 diabetes. Diabetes Care 25:2022-2025
33. Sherif K, Kushner H, Falkner BE 1998 Sex hormone-binding globulin and insulin resistance in African-American women. Metabolism 47:70-74
34. Plymate SR, Moore DE, Cheng CY, Bardin CW, Southworth MB, Levinski MJ 1985 Sex hormone-binding globulin changes during the menstrual cycle. J Clin Endocrinol Metab 61:993-996
35. Bogaty P, Brophy JM, Boyer L, Simard S, Joseph L, Bertrand F, Dagenais GR 2005 Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch Intern Med 165:221-226
36. Wajchenberg BL 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738
37. Festa A, D'Agostino Jr R, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM 2001 The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25:1407-1415